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Abbreviations 
 
 T cells  alpha-beta T cells 
BSA    bovine serum albumin  
Ca
2+
   calcium 
cAMP    cyclic adenosine-3',5'-monophosphate  
CI   chemotactic index    
Ctx.    cholera toxin      
C5a   complement factor 5a 
DAG   diacylglycerol 
dimaprit   S-(3-dimethylaminopropyl)isopthiourea 2HCl (dimaprit-2HCl) 
EGTA   ethyleneglycol-bis(beta-aminoethylether)-N,N'-tetraacetic
 
acid  
ERK   extracellular signal regulated kinase  
FACS   fluorescence cytometry 
FCS   fetal calf serum 
FITC   fluoro-isothiocyanate 
fMLP   N-formyl-Met-Leu-Phe 
FPR   fMLP-receptor  
FPRL1, FPRL2  fMLP receptor-like 1 and  2  
γ T cells  gamma-delta T cells 
GCPR    G protein couple receptor  
H1R, H2R, H3R, H4R histamine receptor subyptes (1-4) 
HTMT   6-[2-(-imidazolyl)ethylamino]-N-(4-trifluoromethylphenyl)  
heptanecarboxamide dimaltate  
IL-    interleunkin-   
IFN-   interferon  
IP3   inositol-1,4,5-trisphosphate 
NK    cell natural  killer cells     
NFB   nuclear factor 'kappa – light – chain –enhancer'  
PBMC   peripheral blood mononuclear cells  
PBS   phosphate-buffered saline     
PE   phycoerythrin    
PIP2   phosphatidylinositol (4,5)-bisphosphate 
PIP3   phosphatidylinositol (3,4,5)-trisphosphate 
PI3K    phosphatidylinositol 3-kinase      
Ptx.    pertussis toxin     
Raji    human Burkitt's lymphoma cell line  
RANTES  regulated on activation-normal T cell expressed and secreted  
thioperamide  N-cyclohexyl-4-(1H-imidazol-4-yl)-1-piperidinecarbothioamide  
maleate salt (thioperamide) 
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Summary 
 
The data collected in this work represent the first evidence that G-protein-coupled 
signalling exist in  T cells via histamine and fMLP receptors. The bigenic amine 
histamine and the bacterial peptide fMLP have been demonstrated to be novel 
chemoattractant factors for circulating human  T cells, which are critical members of 
the immunological tumor surveillance machinery. Here, we analyzed the influence of 
histamine on the interaction of human  T cells with tumor cells such as the A2058 
human melanoma cell line, the human Burkitt's non-Hodgkins lymphoma cell line Raji, 
the T-lymphoblastic lymphoma cell line Jurkat, and the NK cell-sensitive 
erythroleukaemia line K562. We found that histamine inhibits the spontaneous cytolytic 
activity of  T cells in response to these cell lines. The downregulation of  T cell 
mediated cytotoxicity involves the histamine receptor subtype 2 (H2R), the activation of 
Gs proteins and increased cAMP intracellular levels. On the other hand, histamine 
activates the common signalling pathways of chemotaxins such as Gi-protein-dependent 
actin reorganization, the increase of intracellular Ca
2+
 and the induction of migratory 
response in  T lymphocytes. Our data indicate that histamine contributes to the 
mechanism by which tumor cells escape immunological surveillance.  
The bacterial-cell-wall-derived peptide N-formyl-Met-Leu-Phe (fMLP) is a well 
characterized chemotactic factor for phagocytes such as neutrophils, monocytes and 
dendritic cells. Here, we analyzed the influence of fMLP on isolated human peripheral 
blood γδ T cells. We found that fMLP induces intracellular calcium transients, actin 
reorganization, CD11b upregulation and the migration of γδ T cells. Pretreating γδ T cells 
with pertussis toxin inhibited all fMLP-stimulated cell responses, implicating the 
involvement of Gi proteins in the induced signalling cascade. The present data suggest that, 
in addition to phagocytes, N-formyl peptides also regulate the trafficking and activation of 
γδ T cells.  
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Zusammenfassung 
 
Die Kommunikation zwischen Zellen ist eine essentielle biologische Funktion in 
multizellulären Organismen. Externe Signale können durch spezifische Rezeptoren der 
Zielzellen wahrgenommen werden und lösen Protein-Protein-Interaktionen, Protein-
Phosphorylierungen und die Bildung sekundärer Botenstoffen aus und führen 
schließlich zu spezifischen, zellulären Reaktionen. 
G-Protein gekoppelte Rezeptoren gehören der Superfamilie der sogennanten Serpentin 
Rezeptoren an, deren charakteristisches Merkmal sieben transmembranäre Helices sind. 
G-Proteine selbst sind aus drei Unterinheiten (, und γ) aufgebaut. Bindet ein Botstoff, 
beispielsweise Histamin oder fMLP an seinen Rezeptor, so wird durch eine 
Konformationswandlung die Bindungsstelle für G-Proteine freigelegt. Innerhalb des 
Immunsystems sind G-Proteine Regulatoren von zellulärer Reaktionen. Die G-Protein 
gekoppelte Rezeptoren sind an die Einrichtung von verschiedenen Zellfunktionen 
beteiligt. Beispielsweise induzieren Chemotaxine wie fMLP in neutrophilen 
Granulozyten G-Protein-abhängig die gerichtete Migration und die ROS-Produktion der 
Zellen. Mittels RT-PCR, Western blot Analyse und Flow Zytometrie wurden Histamin 
und fMLP Rezeptoren an der Oberfläche von aus dem peripheralen Blut isolierten 
humane γ T Zellen identifiziert. Histamin (2-(4-Imidazolyl)-ethylamin), das biogene 
Amin wird durch Abspaltung von Kohlendioxid aus der Aminosäure Histidin gebildet 
und insbesondere in Mastzellen, basophilen Granulozyten und Nervenzellen 
gespeichert. N-formyl-Met-Leu-Phe (fMLP) ist ein in den Bakterien vorkommender 
chemotaktische Faktor. Es wurde gezeigt, dass Histamin und fMLP als chemotaktische 
Faktoren für humane γ T Zellen funktionieren. Es wurde weiterhin demonstriert, dass 
die Migration der humanen γ T Zellen zu den beiden Faktoren eine Gi-Protein-
abhängige Reaktion der Zellen ist. Wir haben nachgewiesen, dass es in humane γ T 
Zellen für Histamin drei unterschiedlichen Rezeptoren-Untereinheiten (H1, H2, H4) 
existieren. Von denen der Gs-Protein gekoppelte H2-Rezeptor für die Regulierung der 
Zytotoxizität Reaktion und der Gi-Protein gekoppelte H4-Rezeptor für die 
chemotaktische Antwort der humane γ T Zellen auf Histamin verantwortlich ist. 
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1. Introduction 
 
1.1. The immune system  
 
The immune system is an organization of cells and molecules with specialized roles in 
defense against infection. There are two fundamentally different types of responses to 
invading microbes. Innate responses occur to the same extent however many times the 
infectious agent is encountered, whereas adaptive responses become more exact on 
repeated exposure to a given infection [1]. Innate and acquired responses usually work 
together to eliminate pathogens. The innate responses use neutrophils, monocytes, 
macrophages, basophils, mast cells, and eosinophils, natural killer cells, and  T cells. 
The molecular components of innate responses include complement, acute-phase 
proteins, and cytokines [1]. Acquired responses involve the proliferation of antigen-
specific B and T cells. Specialized cells, called antigen presenting cells, present the 
antigen to lymphocytes and collaborate with them in the response to the antigen, to 
initiate the target-specific response. The response of the immune system to pathogens, 
immune complexes, and injured tissues depends in large part on the functional 
relationships between the different immune cells.   
The accumulation of leucocytes at sites of inflammation and microbial infection in 
response to locally produced chemotactic factors is an important feature of the immune 
response [2]. The accumulation of selected populations of leukocytes is an orchestrated 
event that probably involves the coordinated expression of a variety of adhesion 
molecules, target-cell-specific chemokines, cytokines, growth factors and enzymes that 
contribute to the ensuing tissue remodelling, as defined by the degradation of existing 
and the deposition of new extracellular matrix proteins and proteoglycans, and 
angiogensis [3]. A large group of chemotactic factors such as all chemokines, histamine 
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and N-formyl peptides, e.g N-formyl-Met-Leu-Phe (fMLP) engage seven-
transmembrane G-protein-coupled-receptors (GPCRs).  
 
1.2.1. G-protein-coupled receptors (GPCRs)  
 
With nearly 1000 members, G-protein-coupled receptors (GPCRs) constitute the largest 
group of cell-surface proteins that are involved in signal transduction. They account for 
more than 2% of the proteins that are encoded by the human genome [4]. GPCRs are 
often referred as serpentine receptors because they span the plasma membrane seven 
times with -helical segments separated by alternating intracellular and extracellular 
loop regions. The N-terminus is located extracellularly, whereas the C-terminus is found 
intracellularly [5]. These receptors are activated by a diverse array of ligands, from 
peptide and non-peptide neurotransmitters, to chemokines and nucleotides [6.7]. 
Consistent with their ability to recognize many antigens, GPCRs participate in a wide 
variety of physiological functions. GPCRs are also involved in a number of human 
diseases: this involvement is reflected in the fact that they are targets directly or 
indirectly of 50-60% of all known therapeutic agents to date.  
When receptors activated by agonists, the conformation of the transmembrane -helices 
of GPCRs changes profoundly and previously masked G-protein-binding sites appear. 
This, in turn, promotes GDP-GTP exchange on the -subunit, which results in their 
activation. Consequently, Gγ- and GTP-bound G proteins stimulate effector 
molecules. The biochemical changes that are induced are highly dependent on the 
individual receptor-coupling specificity for each of the four families of mammalian G-
protein subunits: s i q or 12/13 [8]. Receptors that are coupled to Gs activate 
adenylyl cyclases, thereby increasing cyclic-AMP levels; whereas those that stimulate 
Gi-family members inhibit adenylyl cyclases and reduce cAMP levels as well as 
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activating phospholipases and phosphodiesterases [8]. Each G protein has a unique 
biological function. The Gs protein activates adenylyl cyclise, resulting in the 
accumulation of cyclic adenosine monophosphat (cAMP) in the cells. Gi proteins are 
highly homologous members of the family of heterotrimeric signal-transducing guanine 
nucleotide-binding proteins (G proteins) involved in coupling numerous receptors for 
extracellular signalling molecules to the inhibition of adenylyl cyclase, the stimulation 
of phospholipase C, or the opening of potassium channels [9, 10, 11]. The activation of 
phospholipase C results in the hydrolysis of phosphatidylinositol bisphosphate (PIP2) 
and the generation of diacylglyceride (DAG), an activator of protein kinase C (PKC), 
and inositol(1,4,5)trisphosphate . [12]. The termination of GPCR signalling cascades 
after agonist activation is highly regulated and can occur through several mechanisms 
[8].  
 
1.2.1.1. Toxins influencing G-protein coupled receptor pathways 
 
There are two main subgroups of G proteins, the cholera-toxin-sensitive G proteins and 
the pertussis-toxin-sensitive ones. In the cholera-toxin-sensitive G proteins, the arginine 
residue present in the carboxy terminal of the  subunit of Gs will be ADP-ribosylated, 
whereas the pertussis toxin ADP ribosylates the cysteine residue in the carboxy terminal 
of the   subunit of Gi and Go proteins while it inhibits their interaction with agonist-
occupied receptors  [13].  
 
1.2.2. The role of adhesion molecules 
 
Leukocytes must engage several sequential adhesion pathways to leave the circulation. 
Initially, tethers are formed by adhesion receptors that are specialized to engage rapidly 
and with high tensile strength. The most important initiators of adhesion are the three 
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selectins expressed on leukocytes L-selectin, endothelial cells (P- and E-selectin), and 
activated platelets (P-selectin) [14]. Selectin-mediated bonds are too impermanent to 
arrest cells at the vessel wall. As the blood flow exerts pressure, adhesion bonds 
dissociate at the cell´s upstream end and new bonds form downstream. This results in a 
rolling motion that is much slower than that of free-flowing cells. To stop rolling, cells 
must engage additional (secondary) receptor molecules, which belong to the integrin 
family. Integrins are obligate heterodimers containing two distinct chains, called the - 
and -subunits. They are expressed on the most of the cells and are responsible for 
anchoring the cells to the extracellular matrix. Only a limited number of integrins are 
expressed in leukocytes, e.g. the 2-integrin CD11b/CD18 [15, 16, 17]. 
 
1.2. Chemotaxis of leukocytes and G-protein-coupled signalling  
 
Chemotaxis is the ability of cells to detect and move towards the source of a 
chemoattractant signal. Such directional migration is essential for a variety of cellular 
processes, including cell movement during development, immune responses and wound 
healing, in addition to the metastasis of tumor cells. In response to chemoattractants, 
leukocytes rapidly polarize in the direction of the signal, forming a pseudopod on the 
side exposed to the highest chemoattractant concentration, and a uropod or a posterior 
domain on the opposite side of the cell. These structures become the leading and trailing 
edges of the migrating cell [18, 19]. The formation of the leading edge results from 
localized chemoattractant-induced F-actin assembly, whereas the cell´s side and 
posterior become enriched in assembled myosin II. The regulation of these cytoskeletal 
components during chemotaxis provides the driving and contracting forces required for 
cell motility [20]. Cells are able to detect and respond to chemoattractant concentrations 
that differ by as little as 2-5% between the front and the back of the cell. These 
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differences are then translated by the cell into a steep intracellular gradient of signalling 
components, leading to an asymmetric cellular response [21]. One of the first 
asymmetric responses to chemoattractant stimulation in leukocytes is the localized 
accumulation of phosphatidylinositol-3 kinases [PI(3,4,5)P3], the product of class I 
phosphatidylinositol-3 kinases (PI3Ks), at the site of the new leading edge [21, 22]. 
PI3K, which is made up of multiple isoforms, comprises a regulatory p85 subunit and a 
catalytic p110 subunit, of which in T lymphocytes p110 and p110 are expressed; 
both participate in the activity of the enzyme [23]. The three catalytic isoforms p110, 
,  are classified as class IA PI3Ks; the only member of the class of IB PI3Ks is p110 
[24, 25]. The pharmacological inhibitors of PI3Ks are wortmannin [26] or LY294002 
[27]. PI3K activation results in binding of p85 to adapters and in turn the enzyme to the 
plasma membrane and subsequently generates PI(3,4,5)P3 and PI(3,4)P2 by activating 
the catalytic subunit p110 [28]. This localized enrichment of [PI(3,4,5)P3] at the 
leading-edge  membrane of the cell recruits and activates proteins that preferentially 
bind to PI(3,4,5)P3, including proteins that contain a plextrin-homology (PH) domain 
(e.g. protein kinase B [Akt/PKB], guanine nucleotide exchange factors [GEFs]) [29]. 
 
1.3. The role of  T cells 
 
The immune system has maintained two different types of T cell receptors (TCRs) 
throughout evolution,  T cells and γ T cells.  T cells form an independent 
population of lymphocytes expressing the  TCR genes [30, 31, 32] and representing a 
complex system of developmentally and functionally differentiated subsets [33].  T 
cells are an ancient type of lymphocytes derived from haematopoetic stem cells; they 
share different characteristics with other immune cells such as the capacity to present 
antigens [34, 35] and the cytolitic effect [34, 36].  T cells participate in the 
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polarization of Th1- and Th2- immune responses by releasing various cytokines and 
helping  T lymphocytes mature [37] and B cells [38].  T cells, unlike  T 
lymphocytes, do not need MHC presentation by antigen presenting cells to recognize 
antigens. They are able to directly recognize natural phosphoantigens derived from 
plants [39], bacteria [40, 41, 42] protozoa [43], endogenous ligands from some tumors 
[47, 48, 49], and viruses [45, 46]. Early events in an immune response stimulate the 
production of cytokines; these direct the subsequent development of T cell subsets with 
discrete patterns of cytokine production. Cytokines secreted by human  T cells are 
able to activate both innate host defenses such as IFN, or IL-2 [34, 50, 48, 35, 49, 51] 
and humoral host defenses with IL-4 and IL-10 [50, 52, 53].   
 
1.3.1.  T cell subtypes: Circulating and resident  T cells 
 
Two main subsets of  T cells are distinguished on the basis of  their location. Resident 
 T cells are found in the skin, uterine and epithelium, whereas the circulating/systemic 
 T cells are found in the peripheral blood or lymphoid tissues [54, 55]. The majority 
of circulating human  T cells express a TCR comprising the variable segments 9 2 
(V9V2 TCR). The functional characteristics of these cells are MHC-unrestricted 
cytolysis, production of Th1 type cytokines such as IFN- and TNF-, and expansion in 
a variety of bacterial or parasite infections [56, 57, 58, 34]. In the peripheral blood of 
most healthy individuals, T cells expressing the V2 gene paired with one particular V 
chain (V9) account for 50% to 90% of the  T cell population [34]. The major 
population of V9V2 T peripheral  T cells is strongly activated by a variety of 
bacteria and parasites [59, 36, 35]. Sequencing the rhesus monkey V9V2 TCR 
revealed a strong sequence homology to the human V9V2 TCR with important 
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preserved sequence motifs [60] macaque and human V9V2 TCR share several 
conserved motifs [61]. Intestinal intraepithelial  T cells frequently express the V1 
gene, which can associate with different V elements [54]. 
 
1.3.2.  T cell antigen recognition 
 
γδ T cells have been shown to recognize classical MHC molecules (MHC I/II) as well 
as nonclassical MHC molecules, such as nonpolymorphic MHC-related CD1 protein  
and the closely related MHC class I b molecules T22 by TCR. MHC molecules are 
recognized as antigens, whereas the loaded peptides on the membrane do not play any 
role as ligands. In addition, γδ T cells can recognize non-MHC molecules, for examples, 
isopentenyl pyrophosphate, heat shock protein (Hsp), MICA/B, ULBP3, virus protein 
directly via γδ TCR or cooperatively through antigen specific receptor, such as NKG2D 
without antigen processing and presentation requirements [62, 63, 64, 65]. 
 
1.3.2.1. Bacterial antigens 
 
Early reports on the reactivity of  T cells suggested that heat-shock proteins were the 
main stimulatory fraction of mycobacteria [66, 67]. However, later studies have shown 
that stimulation of  T cells by M. tuberculosis appears to occur mainly through the 
recognition of the phosphorylated nucleotides TUBag1-4 [68].  
 
1.3.2.2. Amino-bisphosphonates  
 
The antitumor effect of amino-bisphonates mainly results from their capacity to activate 
 T cells, as they have been found to induce V9V2 T cell proliferation in vitro [69] 
and in vivo [70] and to trigger the V9V2 TCR-mediated lysis of tumor lines [69]. 
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V9V2 T cells are stimulated by cognate recognition of human cells pulsed with 
aminobisphosphates, e.g., pamidronate or zoledronate, probably because their 
pharmacological action leads them to accumulate of mevalonate metabolites [69, 71]. 
Amino-bisphosphonates induce V9V2 T cell proliferation in vitro and in vivo, and 
trigger the V9V2 TCR-mediated lysis of many tumor cell lines and reduce the 
survival of autologous myeloma cells [36].  
 
1.3.2.3. Phosphoantigens 
 
The most potent natural phosphoantigen is (E)-4hydroxy-3-methyl-but-enyl 
pyrophosphate, a metabolite of the nonmevalonate pathway of isoprenoidsynthesis, 
which is found in plants, bacteria and protozoa [43]. Less potent phosphoantigens are 
ubiquitous metabolites of isoprenoid synthesis, such as isopentenyl pyrophosphate (IPP) 
[72]. IPP-mediated  T cell activation does not require accessory cells as does the 
activation of the aminobisphosphonate pamidronate [73].  
 
1.3.3. Receptors expressed on the surface of  T cells  
 
1.3.3.1. TCR receptor 
 
1.3.3.1.1. The classical TCR signalling pathway in T lymphocytes  
 
The physiological ligand for T cell activation is a foreign peptide bound to a major 
histocompatibility complex (MHC)-encoded molecules presented on the surface of 
professional antigen presenting cells (APCs) such as dendritic cells (DC) [15]. 
Biochemical signals initiated by the TCR receptor make up / subunits and signal-
transducing subunits , , , and ; these determine the specifity of the TCR receptor 
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activation and events initiated by other membrane proteins such as MHC receptors 
CD4/CD8; costimulators such as CD2, CD28 or integrins modulate the intracellular 
signaling thresholds required to initiate a T cell immune reaction [74]. The activation of 
tyrosine kinases initiates a cascade of signalling pathways in T cells resulting in the 
activation of small GTPases-signalling networks and the regulation of inositol 
phospholipid metabolism: this regulation is responsible for controlling intracellular 
calcium (Ca
2+
) and the activity of diverse serin/threonine kinases, including members of 
the PKC family and phosphatidyl inositol-3 kinase (PI3K)-controlled serin kinases [29]. 
Unlike  T,  T cells are endowed with the capacity to interact with low-molecular-
mass-phosphate-containing nonprocessed antigens, such as pyrophosphomonoesters 
[72] and alkylamines [39]. Recognition of these antigenic compounds is mediated by 
TCR but does not require presentation by conventional MHC molecules [75, 76]. 
 
1.3.3.1.2. NKG2D receptor 
 
NKG2D belongs to a sub-family of C-type lectin-like receptors, which have lost the 
ability to bind both calcium and carbohydrate. In addition to TCR ligation, the 
activation of V9V2 T cells is modulated by a range of inhibitory and activating NK-
cell receptors [77, 78]. 
NKG2D ligation is known to provide a powerful co-stimulus for the antigen-mediated 
activation of both CD8
+
 and V9V2 and intraepithelial V1V1 T cells; however, the 
signalling pathways leading to the activation of these cell types are poorly understood. 
In V9V2 T cells, activation through NKG2D receptors happens independently of the 
antigen, as also happens in the NKG2D-mediated activation of NK cells [36].  Several 
lines of evidence show that both  T cell populations have antitumor reactivity [79, 48, 
80], which they perform with their production of perforin [54, 50, 80] and granzymes 
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[34, 81]. Certain tumors and lymphomas activate  T cells via endogenous ligands in 
 TCR-dependent fashion [75, 48]; other ligands of tumors or transformated cells bind 
the NK cell receptor NKG2D on the surface of  T cells [79].   
  
1.3.3.2. The role of  T cells as effector cells: the role of chemokines and cytokines 
 
Early during the course of infection, cytokines produced by  T cells may help 
eliminate pathogens and contribute to effective cellular immunity against intracellular 
bacteria and parasites. V2 T cells display a range of innate effector functions, 
including the rapid secretion of chemokines MIP-, MIP-, or RANTES [82, 83] and 
cytokines TNF- and INF-γ [84, 85]. 
 
1.3.3.2.1. Response to chemokines  
 
Chemokines or chemotactic cytokines are a family of small (7-15 kDa), inducible 
proteins, which can be classified into four families: C-X-C chemokines or -
chemokines, CC or -chemokines C or γ-chemokines, and CX3C or δ-chemokines.  
Chemokines are implicated in multiple pathological processes, such as allergic 
disorders, autoimmune diseases and ischemia [12]. In addition to chemotaxis, 
chemokines have been shown to modulate a number of biological responses in 
leukocytes, including cellular activation, adhesion, enzyme release, degranulation, 
tumor cell lysis, and intracellular microbe death [86].  
MCP-1/CCL2 [87], RANTES/CCL5, MIP-1/CCL3 and MIP-1/CCL4 were found to 
chemically attract  T lymphocytes and circulating  T cells, whereas neither  nor 
 showed response to IL-8/ CXCL8 or IFN-inducible protein 10 (IP-10/CXCL10) [88, 
89]. The corresponding chemokine receptors - seven-transmembrane-spanning G 
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protein-coupled receptors - share structural features, and some of which are involved in 
intrathymic [90, 91] and memory T cell development, in orchestrating T and B cell 
interactions and in differentiating effector T cells [87, 92].  
 
1.3.3.3. The role of  T cells as effector cells: the way of killing, cytolytic activity 
 
 T cells not only inhibit the early stages of tumor development but also limit the 
progression of neoplastic cells; combined, these functtions suggest there are two or 
more different antitumor mechanisms in these cells. In summary, mouse studies have 
elucidated three different pathways by which  T cells may provide anticancer 
activities; direct killing of transformed cells, early IFN- production and critical 
immunoregulatory function.  T cell lines have been shown to efficiently kill extra- 
and intracellular M. tuberculosis bacilli through the release of the cytotoxic molecule 
granulysin, although granulysin kills both extra- and intracellular M. tuberculosis, 
eliminating the latter requires perforin [59].  Activated  T cells are shown to lyse 
target cells also by producting granzymes and perforin [36].   
 
1.3.3.3.1.  T cells in the tumor microenvironment 
 
The broad antigen-specific recognition of hematopoietic tumors by V9V2 T 
lymphocytes results in cytotoxic activity, inducing Th1 cytokine production and 
proliferation [77, 93]. Like NK cells, V9V2 T lymphocytes exert a cytotoxic activity 
that is controlled at the effector level by the expression of killer Ig-like receptors (KIR) 
[94] which interact with major histocompatibility complex class I (MHCI) molecules at 
the surface of the target [78, 95]. Tumor cell lines which are sensitive to this NK-like 
 20 
cytolytic activity, such as the chronic myelogenous leukaemia cell line K562, often lack 
the ability to express MHC-class I molecules [96, 97, 98].  
Some tumors and lymphomas, such as the B cell line Daudi, express endogenous 
ligands, which in turn activate  T cells in a V9V2 T cell-dependent fashion [75]. 
Moreover, both the percentage and the absolute number of circulating  T cells are 
known to be significantly reduced in patients with cutaneous primary melanoma, thus 
suggesting a specific deficit for this lymphocyte population. The reduction of  T cells 
correlated with the decrease of the V2 T cell subset, which is involved in the reactivity 
toward microbial antigens and tumor cell antigens. The in vitro expansion of  T cells, 
particularly the V2 T subset isolated from peripheral blood of patients with cutaneous 
primary melanoma, was significantly reduced; in summary, not only the proliferative 
capacity but the percentage of  T cells producing either TNF- or IFN- is 
significantly reduced in melanoma patients  [99]. 
 
1.3.3.3.1.  T cells in immunosuppression and cancer immunotherapy  
 
Human  T cells are prime effector cell candidates for immune therapy against 
malignancy, since there is a growing evidence that V9V2 T cells have cytotoxic 
antitumor activitiy against a large range of tumor types [100, 101]. Activated V9V2 T 
cells provide alternative mechanisms for tumor-targeted recognition and killing, 
increasing the possibility that treatment with other modalities may enhance antitumor 
effects. Pre-treating tumor cells with low concentrations of chemotherapeutic agents 
may lead to their isoprenoid-mediated recognition and perforin following TCR-
dependent rapid killing by V9V2 T cells [102]. 
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1.4. Characterization of histamine and fMLP as chemoattractant factors  
 
Since circulating  T cells have a pivotal role in host defense against invading 
pathogens, bacteria, and viruses as well as in the tumor microenvironment, and the 
existence of G-protein-coupled receptors on the surface of these cells has been not 
thoroughly examined, in this work we investigated the signal transduction pathways for 
histamine and fMLP in circulating  T cells. All the chemoattractants mentioned above 
are ligands of GPCRs and influence the immune response of leukocytes.  
 
1.4.3. Histamine 
 
Histamine (-imidazolylethylamine) is an endogenous mediator involved in various 
responses of immune and non-immune cells; it is stored in the granules of tissue mast 
cells and blood basophlis and is released upon activation by IgE cross-linking [103]. 
The half-life of histamine in plasma is < 20 minutes, whereas the suppression of T-cells 
and phagocytes lasted  4 hours after subcutane histamine injection [104]. 
Beyond its physiological functions, histamine was described as an autocrine and 
paracrine/exogene growth factor for malignant melanomas and leukemic cells. 
Histamine and histidine decarboxylase (HDC) [105], the only enzyme that catalyzes 
histamine production, has been proven to be present in elevated concentrations in 
proliferating tissues, including tumor cells [106]. In the case of the myeloproliferative 
disease of chronic myeloid leukaemia (CML), this gene was the first known leukaemia-
specific oncogene reported to be involved in the regulation of histamine production in 
neoplastic cells [107]. Malignant haematopoetic diseases characterized by 
hyperhistaminism in peripheral blood respond favorably to INF-, an NK- and T-cell-
activating cytokine [107, 108]. Histamine also interacts directly with H2 receptors (H2R) 
on T-cells to inhibit T-cell proliferation and cytokine production [109]; however, the 
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inhibition of T-cell function may not be expressed if histamine is combined with IL-2 
[110, 111].  
 
1.4.3.1. Histamine receptor subtypes 
 
Histamine receptors are expressed on the surface of human monocyte-derived dendritic 
cells [112], eosinophils [113], mast cells [114], T cells, keratinocytes [115], and NK 
cells [116]. The effects of the numerous physiological activities of histamine are 
mediated by several histamine receptors. To date, four subtypes (H1R, H2R, H3R and 
H4R) of histamine receptors have been identified and cloned. All belong to the seven 
transmembrane domain G-protein- coupled receptor family, and coupled G proteins, and 
subsequently activated intracellular signals have been characterized [117]. In vitro 
studies made in human peripheral blood lymphocytes have demonstrate that histamine 
and the histamine receptor 2 (HR2) agonists, impromidine and dimaprit, were effective 
in suppressing cell proliferation induced by low rather than high doses of PHA [118, 
119, 120].    
 
1.4.2. Formyl-methyl-leucyl-phosphate (fMLP) 
 
N-formyl-methionine-leucine-phenylalanine (fMLP) is the prototype for N-formylated 
bacterial peptides and also a chemoattracting tripeptid. Its receptor in humans was 
pharmacologically defined as a high affinity binding site on the surface of neutrophils 
[121]. fMLP stimulates glucose uptake in CHO cells expressing chemoattractant-
receptors which is due to the translocation of GLUT1 mediated by the G subunit 
through unknown pathways [122]. The fMLP-stimulated 2-DG uptake of human 
peripheral blood cells is inhibited by the PKC inhibitor calphostin C and tyrosine kinase 
inhibitor genistein [123]. In phagocytes, the chemoattractant fMLP activates the FPR to 
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stimulate diverse biological processes including chemotaxis, transcriptional activation, 
and actin reorganization [124].    
 
1.4.2.1. The formyl peptide receptor (FPR) 
 
First reports of the cloning and functional expression of human fMLP receptor, 
published in the early 1990s [125, 126], found the fMLPR to be constitutively active 
[127]. The formyl peptide receptor (FPR) genes of non human primates are 95-99% 
identical of their human ortholog [128]. Expression of the receptor has been described 
in phagocytic leukocytes, monocytes and neutrophils [129, 130], and is observed in 
immature dendritic cells, microglial platelets, spleen and bone marrow, non-
haematopoetic cells and tissues such as hepatocytes, fibroblasts, astrocytes, neurons of 
autonomic nervous system, lung and lung carcinoma cells, thyroid, adrenals, heart, the 
tunica media of coronary arteries, uterus, ovary, placenta, kidney, stomach and colon 
[131]. The first ligand described for the FPR was the prototypical formylated peptide 
fMLP derived from E. coli, which binds and activate FPR with high affinity [131]. 
Because the formylation of peptides also occurs in mitochondria; the secondary release 
of formylated peptides secondary to cell death, might allow for the attraction of 
phagocytic leukocytes through FPR. Indeed disrupted mitochondria purified bovine 
mitochondrial N-formylatmethionyl-proteins, but not non-formylated mitochondrial 
proteins; the latter are chemoattractants for neutrophils in vitro [132]. The fMLP 
receptor is coupled to Gi proteins, as indicated by the total loss of cell response to their 
respective agonists upon exposure to pertussis toxin [121, 133, 134]. More specifically, 
the fMLP receptor is coupled to Gi1, Gi2 [135, 136, 137], Gi3 but coupling to Go, Gz, 
G16 [138] and in xenopus oocytes to Gq [139] has also been described [140, 141]. After 
ligation of the FPR, the heterodimeric G protein is activated, which dissociates into  
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and  subunits; these subunits then activate the phospholipase C (PLC). The hydrolysis 
of phosphatidylinositol 4,5-bisphoshate (PIP2) by PLC generates IP3 [142], which 
releases intracellular calcium ([Ca
2+
]i) from endoplasmatic reticulum stores, and 
diacylglycerol (DAG); DAG, which activates protein kinase C (PKC) isofoms. The 
phosphoinositide 3-kinase (PI3K)-Akt/PKB pathway is also activated, in particular 
PI3K, which is the isoform coupled to most chemoattractant receptors [143, 141]. 
Since fMLP such as IL-8 induce Ca
2+
 efflux and leukocyte chemotaxis, which are 
sensitive to PTX treatment, the fMLP receptor may use the same signal transduction 
pathways as the IL-8 receptors [144]. Co-transfection assays have been demonstrated 
that the fMLP receptor can specifically activate PLC 2 but not PLC 3 in a PTX-
sensitive manner; thus, the interaction of the receptor with the G protein causes the 
release of the G subunits, which in turn specifically activate PLC 2 [138]. 
 
1.5. The aim of the study 
 
The biogenic amine, histamine, has been described as playing a pathophysiological 
regulatory role in the cellular processes of various immune cells. This work analyzes the 
biological activity of histamine-influencing human peripheral blood  T lymphocytes, 
which are critical members of the immunological tumor surveillance. The bacterial cell-
wall-derived peptide N-formyl-Met-Leu-Phe (fMLP) is a well characterized chemotaxin 
for phagocytes such as neutrophils, monocytes and dendritic cells. Both fMLP and 
histamine receptors belong to the family of G-protein-coupled seven-transmembrane 
receptors (GPCRs). Receptor ligand interactions are known to activate intracellular 
signal transduction pathways in neutrophils and monocytes, leading to directed motility, 
phagocytosis, superoxide anion generation, and degranulation responses culminating in 
death and elimination of invading microorganisms. 
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In this regard, the present study addresses the biological questions below: 
 
1)   What is the role of fMLP and histamine in the chemtaxis of human circulating  T 
lymphocytes? 
2) What is the role of histamine in the cytolytic activity of human circulating  T 
lymphocytes? 
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2. Materials and methods 
 
2.1. Materials 
 
2.1.1. Biological Material 
 
2.1.1.1. Cell lines 
 
The human metastatic melanoma line A2058, from a brain metastasis in a 43-year-old 
man [145], the human Burkitt's non-Hodgkin lymphoma cell line Raji [146], the T-
lymphoblastic lymphoma cell line Jurkat, established from the peripheral blood of a 14-
year-old boy with acute lymphoblastic leukemia (ALL) at first relapse in 1976 [147]  
and the erythroleukaemia cell line K562 originating from patients with chronic myeloid 
leukaemia and blast crisis [148] were maintained at 37
o
C in a 5% CO2 incubator in 
RPMI 1640 supplemented with 10% fetal bovine serum, 10 U/ml penicillin, 10 U/ml 
streptomycin, and 1 mM L-glutamine [149]. 
 
2.1.1.2. Human peripheral blood  T lymphocytes 
 
The use of human cells was approved by the Research Ethics Board of the Friedrich 
Schiller University of Jena. Human peripheral blood  T lymphocytes used in the work 
were isolated from the buffy coats of healthy volunteers produced by the Institute of 
Transfusion Medicine of Friedrich Schiller University of Jena. 
 
2.1.2. Cell culture medium 
 
Isolated human peripheral blood  T lymphocytes were cultured in RPMI medium 
supplemented with 10% fetal calf serum (FCS), 10 U/ml penicillin, 10 U/ml 
streptomycin, and 1 mM L-glutamine. 
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2.1.3. Reagents 
 
Albumin from bovine serum (BSA)    Sigma-Aldrich, Taufkirchen 
Cholera toxin (Ctx.)      Sigma-Aldrich, Taufkirchen 
DNA Molecular Weight Marker    Roche Diagnostics, Mannheim 
Dimethylsulfoxid (DMSO)    Sigma-Aldrich, Taufkirchen 
FastStart Taq DNA Polymerase Kit    Roche Diagnostics, Mannheim 
Fetal bovine serum, 10 U/ml     Promocell, Heidelberg 
N-formyl-Met-Leu-Phe (fMLP)   Sigma-Aldrich, Taufkirchen, 
Fura/2AM       MERK, Darmstadt 
L-glutamine       Promocell, Heidelberg 
Hank´s balanced salt solution (Hank´s BSS)   Promocell, Heidelberg 
High Pure RNA Kit      Roche Diagnostics, Mannheim  
Histamine       Sigma-Aldrich, Taufkirchen  
HTMT dimaleate       TOCRIS (BIOZOL), Eiching 
rHu interleukine-2 (Proleukine)    Chiron, Ratingen 
imetit        TOCRIS (BIOZOL), Eiching 
MicroScint-40 cocktail     PerkinElmer, Jügesheim 
Na2
51
CrO4 (100Ci)    Amersham, Freiburg 
NBD-phallacidin      Invitrogen GmbH,  Karlsruhe 
Phosphate buffered saline (PBS)   Promocell, Heidelberg 
Penicillin (10 U/ml)      Promocell, Heidelberg 
Phaseolus vulgaris phytohemagglutinin (PHA)  Sigma-Aldrich, Taufkirchen 
Pertusis toxin       Sigma-Aldrich, Taufkirchen 
Primers       Invitrogen GmbH, Karlsruhe 
RANTES      Promokine, Heidelberg 
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RPMI 1640 culture medium     Promocell, Heidelberg 
SeaKem LE agarose      Cambrex, Tuafkirchen 
Streptomycin, and 1 mM     Promocell, Heidelberg 
Thioperamide malate salt (T123)    Sigma-Aldrich, Taufkirchen 
Triton-X-100       Sigma-Aldrich, Taufkirchen 
Wortmannin       Sigma-Aldrich, Taufkirchen 
 
2.1.4. Antibodies  
 
2.1.4.1. Flow cytometry analysis antibodies 
 
anti-TCR  hapten-antibody    Miltenyi, Bergisch Gladbach 
anti-hapten microbeads-FITC antibody  Miltenyi, Bergisch Gladbach 
goat anti-mouse-FITC (sec. AB)  AL-Immunotools, Friesoythe 
gouse anti-human cAMP antibody  Abcam, Cambridge 
mouse anti-human CD88-FITC antibody Acris Antibodies, Hiddenhausen 
mouse anti-human fMLPR-PE antibody BD Biosciences, Heidelberg 
mouse anti-human V9 TCR antibody  BD Biosciences, Heidelberg 
mouse anti-human V2 TCR antibody BD Biosciences, Heidelberg 
mouse anti-human-TCR-/-1 antibody  BD Biosciences, Heidelberg 
mouse anti-human-TCR-/-1 antibody  BD Biosciences, Heidelberg 
 
2.1.4.2. Western blot analysis antibodies  
 
goat anti-human actin [(I-19:sc-1616)]  Santa Cruz Biotechnology, Heidelberg 
goat anti-human H1R (A20) antibody  Santa Cruz Biotechnology, Heidelberg 
goat anti-human H3R (P-15) antibody  Santa Cruz Biotechnology, Heidelberg 
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goat anti-human H4R (IL-15) antibody  Santa Cruz Biotechnology, Heidelberg 
rabbit anti-human H2R (H-70) antibody Santa Cruz Biotechnology, Heidelberg 
 
2.1.5. Consumables 
 
Cell culture flasks 75 cm
2
    Greiner, Frickenhausen 
Cell culture plates (12-, 24-, 96-well)  CellStar,  
LS-Separation columns   Miltenyi, Bergisch Gladbach 
Minifac tubes      Costar, Jena 
Pipettes (5 ml, 10 ml, 25 ml)   Greiner, Frickenhausen 
Pipette tips (10 l, 100 l and 1000 l) Greiner, Frickenhausen 
Plastic tubes (500 l, 1000 l, 2000 l) Eppendorf, Hamburg 
Syringes 60 ml Braun     Braun, Melsungen 
Tubes (15ml, 50 ml)     Greiner, Frickenhausen 
 
2.1.6. Buffers and solutions 
 
Ammonium-chloride solution: 41.5 g NH4Cl, 0.5 g KHCO3, 0.179 g EDTA, 500 ml 
H2O(dest.) 
PBS-BSA-EDTA solution: PBS pH 7.2, 0.5% BSA, 2 mM EDTA 
EDTA solution: 0.5M, pH8.0 
Ethidium bromide: 10 mg/ml 
TBE buffer (5x), 1000 ml:  
54 g Tris-base, 27.5 g boric acid, 20 ml 0.5 M EDTA (pH 8.0) 
NET-G buffer (1x):  
Tris-HCl pH 8.0 10 mM, NaCl 150 mM, EDTA 5 mM, Tween 20 0.05 % (v/v), 
Gelatine 0.05 % (v/v) 
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Running buffer (4x):  
Tris-base, SDS 10% (v/v) 
Stacking buffer (4x):  
Tris-HCl pH 6.8 0.5 M, SDS 10 % (v/v) 
Running gel (10%):  
H2O(dest.) 6.0 ml, Running buffer (4x) 3.6 ml, Acrylamide Stock 4.8 ml 
Stacking gel (5%):  
H2O(dest.) 2.8 ml, Stacking buffer (4x)  
1.2 ml, Acrylamide Stock 0.8 ml 
Protein electrophoresis buffer (10x):  
Tris-HCl pH 8.3 250 mM, Glycin 2 M, SDS 1 % (v/v) 
Transfer buffer:  
Tris 25 mM, Glycin 192 mM, Methanol 20 % (v/v) 
Stripping buffer: 
Tris-HCl pH 6.7 62.5 mM, 2-mercaptoethanol 100 mM, SDS 2% (v/v) 
 
2.1.7. Equipment 
 
Autoclave      Varioklav, Freiburg 
Balance      Sartorius, Göttingen 
Centrifuge 5804R     Eppendorf, Hamburg 
Centrifuge RC-3B Sorvall    Heraeus, Langenselbold 
Digital fluorescence microscope unit Atofluor Zeiss, Jena 
Electrophoresis gel chambers Gibco BRL Life Technologies Inc., USA 
Flow cytometer FACSCalibur   BD Biosciences, Heidelberg 
Freezer  -20°C      Siemens, Berlin 
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Freezer Hera -80°C     Heraeus, Langenselbold 
Gamma counter TopcountTM    Packard Instruments,  
Heating block HB-130    Unitek, Freiburg 
Incubator CO2      Sanyo, Sakata, Japan 
Laminar-Air HB 2472 workbench   Heraeus, Langenselbold 
Microplate Reader Emax    Molecular Devices, Freiburg 
Microscope Telaval 3     Carl Zeiss, Jena 
Pipettes Easypet    Eppendorf, Hamburg 
Pipettes (20ml, 200ml, 1000ml)  Gilson, Hamburg 
Power supply, PowerPac 300    Bio-Rad, USA 
Thermomixer comfort     Eppendorf, Hamburg 
Vortex       Bender&Hobein, Freiburg 
 
2.2. Methods 
 
2.2.1. Separation of blood leukocytes using the Ficoll-Paque gradient 
 
A 50 ml buffy coat was diluted 1:1 with PBS (v/v). Carefully, 25 ml of the cell 
suspension was layered over 15 ml Ficoll-Paque PLUS solution in 50 ml conical tubes 
and centrifuged at 1800 rpm for 30 min at 20°C, without braking. Differential migration 
during centrifugation results in the formation of layers containing different cell types 
(Figure 2.2.1). The bottom layer contains aggregated erythrocytes. The layer above the 
erythrocyte layer contains mostly granulocytes. Because of their low density, the 
lymphocytes are found at the interface between the plasma and the Ficoll-Paque 
gradient with other slowly sedimenting particles (platelets and monocytes). The 
interphase cells (lymphocytes, monocytes and thrombocytes) were transferred by 
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Pasteur pipette to a new conical tube and subjected to short washing steps, with a 
balanced salt solution to remove platelets, Ficoll-Paque and plasma. 
 
 
 
 
 
 
 
Figure 2.2.1. Differential migration during centrifugation results in the formation of layers containing different cell types.  
 
2.2.1.1. Preparation of  T cells  
 
The use of human cells was approved by the Research Ethics Board of the Friedrich 
Schiller University of Jena. Peripheral blood mononuclear cells (PBMCs) were isolated 
using the Ficoll separation protocol [33]. Briefly, a density gradient centrifugation of 
buffy coats was performed. The leukocyte-containing pellet was resuspended in 
phosphate-buffered saline (PBS) pH 7.2, supplemented with 0.5 % BSA and 2 mM 
EDTA, and the cells were labelled with an anti-TCR  hapten-antibody and anti-hapten 
micro-beads-FITC antibody. Labelled cells were separated with magnetic separation 
columns. Positive selected  T cells were cultured for 7-10 days in the presence of 
phaseolus vulgaris phytohemagglutinin (PHA) (2 g/ml) for 3 days and IL-2 (100 
IU/ml) until day 7 [80, 79, 99].  
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2.2.2. Flow cytometer 
 
The flow cytometer enables a cell population to be acquired on the basis of its cell size 
and granularity. Additionally, surface molecules, or the purity or vitality of a cell 
population can also be examined by fluorescence. Purified cells and cells being cultured 
for 7-10 days were incubated with FITC-conjugated mouse anti-human-TCR-/-1 
(1:200, BD Pharmingen) monoclonal antibodies for 30 min at 4°C. Isotype matched 
antibodies (IgG1 control, Immunotools) were used as negative control. Analysis was 
done with a FACSCalibur flow cytometer (BD Biosciences). All experiments were done 
with a purity of 96-99% of TCR positive T cell population. The cell viability was 
measured with the trypan blue exclusion test of cell viability and we accepted 
populations with a cell viability of min. 95%.   
 
2.2.3. mRNA isolation, reverse transcription and polymerase chain reaction (RT-PCR) 
analysis  
 
mRNA was isolated from 1x10
6
 human peripheral blood  T cells using a High Pure 
RNA isolation kit. A Fast Start Taq cDNA Polymerase Kit and a Fast Start Taq DNA 
Polymerase kit were used to obtain cDNA and PCR products. The primers were 
designed to recognize sequences specific for each target cDNA: 
H1R, (403 bp) : sense 5´-CATTCTGGGGGCCTGGTTTCTCT-3´ ;  
antisense 5´-CTTGGGGGTTTGGGATGGTGACT-3´ 
H2R, (497 bp): sense 5´- CCCGGCTCCGCAACCTGA-3´ 
  antisense 5´-CTGATCCCGGGCGACCTTGA-3´  
H3R, (589 bp): sense 5´-CAGCTACGACCGCTTCTTGTC-3´ 
antisense 5´-GGACCCTTCTTTGAGTGAGC-3´ 
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H4R, (396 bp): sense 5´-GGTACATCCTTGCCATCACATCAT-3´ 
  antisense 5´-ACTTGGCTAATCTCCTGGCTCTAA-3´ 
fMLPR (  bp): sense 5´ TTC CGG ATG ACA CAC ACA GT 
  antisense 5´ TCC GAA CAA GTT GAT GTC CA 
The phases of the PCR process were: 
The initial phase: the denaturation of the DNA-double strand at 95ºC for 3 minutes 
Main cycles: the amplification of the DNA with variable number of cycles (in three 
steps): 
a. denaturation of the DNA-double strand (94ºC, 1 minute) 
b. hybridization of the specific primers to the single-strand DNA (58 ºC, 60 ºC) 
c. the Taq-polymerase chain reaction (amplification)  (72 ºC, 1 minute) 
The final phase: Taq-polymerase chain reaction (End-polymerization) (8 minutes) 
 
2.2.4. Mobilization of Ca
2+
 transients 
 
Intracellular free Ca
2+
 was measured in Fura-2-labeled  T cells using the digital 
fluorescence microscope unit Attofluor (Zeiss, Oberkochen, Germany).  The purified 
circulating  T cells were resuspended in Hank´s 1% BSA solution and were loaded 
with 4 μM Fura-2/AM. The suspension was then incubated in dark, 37ºC for 30 
minutes. After the incubation cells were washed two times and were resuspended in 
buffer and measured in dark. After the stimulation the fluorescence was measured and 
the ratio was calculated from the absorption between the wavelength 340 nm and 380 
nm [150]. 
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2.2.5. Filamentous (f) actin measurements  
 
Probes of stimulated  T cells (106 /ml; 50ul/probe) were fixed in a 7.4 % 
formaldehyde buffer and mixed with the staining mixture containing 7.4 % 
formaldehyde, 0.33 μM NBD-phallacidin and 1 mg/ml lysophosphatidylcholine. The 
fluorescence intensity was measured by flow cytometry. The relative f-actin content was 
compared to unstimulated controls [151].  
 
2.2.6. Migration assay  
 
The chemotaxis of isolated human peripheral blood  T cells was performed in 48-
well-microtechnic chambers from Neuro Probe (Gaithersburg, US). Wells in the bottom 
of the chamber were filled with 29 l medium containing the indicated concentration of 
stimulus. Over this filled chamber, a polycarbonate membrane (thickness 10 m, 
diameter of the pores 8 m) and a gasket made of silicone was fixed. The device was 
screwed on the top of the gasket and the cells were added in 29 l/well (resuspended in 
a concentration of 1x10
5
/ml) in the upper wells of the chamber. For the assay, the 
chamber was incubated for 240 minutes at 37C. The non-migrating cells from the wells 
of the upper chamber were removed after the incubation period. The filter and gasket 
were then removed and the cells from the bottom chamber were collected, fixed in 
formaldehyde (3.7 %) and counted by flow cytometry. A chemotactic index (CI) was 
calculated as the ratio between stimulated and random migration.  
 
2.2.7. In vitro cytotoxicity assay  
 
Cytotoxicity was determined with a standard 
51
Cr release assay. Target cells were 
labeled at 37
oC for 1 h with 100 μCi Na2
51
CrO4. Cells were washed and resuspended at 
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a cell density of 1×106 cells/ml in RPMI 1640 culture medium supplemented with 2 % 
fetal calf serum. Effector and target cells at different ratios (10:1; 5:1 and 2.5:1) were 
placed into individual wells of 96-well plates in a total volume of 200 μl at 37oC for 4 h. 
After incubation, 100 μl culture supernatant was collected from each well, mixed with a 
MicroScint-40 cocktail and analyzed with a gamma counter (TopcountTM, Packard 
Instruments). To obtain the value of total lysis, target cells were incubated with 2 % 
Triton-X. The percentage of specific lysis was calculated using the following formula: 
(experimental release - spontaneous release) 
 
 
2.2.8. Measurement of cAMP levels  
 
 T cells (1 x 106 /ml) were fixed and made permeable before the intracellular staining 
was performed. The amount of intracellular cAMP in the  T cell preparation was 
determined by flow cytometry [152].  
 
2.2.9. Western blot analysis  
 
2.2.9.1. Lysis of the cells  
 
Equal numbers of cells were washed and resuspended in PBS in 1.5 ml Eppendorf tubes 
and stimulated at 37°C. Supernatants were removed and cell pellets were transferred to 
ice and resuspended in an appropriate volume of lysis buffer containing 0.5 % of the 
detergent NP-40. Cell membranes were dissolved, while the cell cores and remaining 
cell compartments remained intact and were separated by centrifugation. The different 
protease inhibitors were added to the lysis buffer directly before use. 
 
        (maximum release - spontaneous release)  
 
 
x 100 
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Lysis buffer: 20 mM Tris-HCl pH 8.0; 137 mM NaCl; 2.7 mM KCl; 1 mM MgCl2; 1 
mM CaCl2; 0.5% NP-40; 0.5 mg/ml BSA; 1 mM Na3VO4; 1 mM PMSF; 21 μg/ml 
Aprotinin; 12 μg/ml AEBSF; 5 μg/ml Leupeptin; 5 μg/ml Pepstatin A. 
 
After 10 min on ice, the lysates were centrifuged (15 min, 14000 rpm, 4 °C) and the 
NP-40 soluble fraction containing membranes and cytosolic proteins were collected and 
transferred into 1.5 ml eppendorf tubes. 
 
2.2.9.2. SDS-Polyacrylamide-Gel electrophoresis (SDS-PAGE) 
 
After cells were lysed, the NP40-soluble fraction contained in the supernatant was 
removed and diluted with 5x Laemmli sample buffer [153] and heated to 95
o
C for 5 
minutes. Samples (20 μg protein/ lane) were electrophoresed in 10% SDS 
polyacrylamide gels (80 mA). Proteins separated by SDS-PAGE were transferred from 
the gel to PVDF membranes (HybondTM ECL
TM
, Amersham Biosciences) by 
electrophoresis (Western blotting) 50V for 90 min. The primary antibody was diluted 
1:2000 with NET-G buffer and incubated 12 hr at 4°C. After being washed with NET-G 
buffer, the membrane was incubated with the secondary antibody (1:10000 in NET-G) 
for 1 hour at room temperature. After being washed, the protein of interest was detected 
by enhanced chemical luminescence (ECL) utilizing the reaction of Luminol and H2O2. 
For this purpose, the membrane was incubated with the ECL (Perbio, Bonn, Germany) 
reagents for 1 min and the chemiluminescence signal was visualized with the Bio 
Imaging System MF-ChemiBIS 3.2 (Biostep, Germany). 
To reprobe the membrane with different antibodies, the previously applied antibodies 
first had to be removed. For this purpose, the membrane was incubated with 100-200 ml 
stripping buffer for 45 min at 56°C. The membrane was then washed several times with 
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NET-G (1x), until no residual 2-mercaptoethanol could be detected. The blot was again 
blocked in NET-G (10x) for 1 h, and a new primary antibody applied as described. 
 
2.2.10. Statistical analysis  
 
Significant values (p<0.05) were determined using the nonparametric two-tailed 
Student’s t-test. 
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3. Results 
 
3.1. Histamine and ?⁣?汬猺⁴??⁩?癯汶????琠??⁰??瑵獳??瑯硩?慮?⁣?潬敲
瑯硩?獥?獩瑩癥⁦???瑩潮猠潦⁩獯?慴????? 慮⁰ ?楰???慬⁢汯潤??⁬祭??潣祴???
 
3.1.1.  T cells expressed histamine receptors: H1R, H2R, and H4R mRNAs 
 
In order to characterize the biological activity of histamine in  T cells, the expression 
of different histamine receptor subtypes was analyzed. Using reverse transcriptase and 
polymerase chain reaction (RT-PCR) analysis, the expected products for the H1R, H2R 
and H4R subtypes were detected in isolated human-peripheral-blood  T cells. In 
contrast, the H3R was undetectable (Fig. 1). Moreover, H1R, H2R and H4R expression in 
 T cells at the protein level has been shown by western blot analysis (Fig. 2).   
 
 
 
Fig. 1: Expression of mRNA of H1R, H2R and H4R in isolated human peripheral blood ?吠
汹?灨?捹?敳? (A)  T cells were isolated from human peripheral blood and the expression of mRNA for 
histamine receptors was analyzed. Lane 1) DNA molecular weight marker XIV (100-1500bp); lane 2) 
H1R (403 bp); lane 3) H2R (497 bp); lane 4) H3R (589 bp); lane 5) H4R (396 bp); lane 6) 2-microglobulin 
(259 bp). Experiments were repeated three times with identical results. 
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Fig. 2: Expression of H1R, H2R and H4R at a protein level in isolated human peripheral blood ?吠
汹?灨?捹?敳?  T cells were isolated from human peripheral blood and the expression of different 
histamine receptor subtypes was analyzed by western blot analysis. Block 1) H1R (56 kDa), actin (43 
kDa); block 2) H2R (59 kDa), actin (43 kDa); block 3) H3R (70k Da), actin (43 kDa); block 4) H4R (78/90 
kDa), actin (43 kDa). Experiments were repeated three times with identical results. 
 
 41 
3.1.2. Histamine induces actin polymerization, intracellular Ca
2+
 mobilization, and 
chemotaxis in  T cells through pertussis toxin-sensitive Gi proteins 
 
Histamine induces Ca
2+
 transients in different types of leukocytes [154]. In accordance 
with the literature histamine also induced a rapid and concentration-dependent 
intracellular response in human  T cells isolated from peripheral blood (Fig. 3A). Ca2+ 
transients are mainly induced by mobilization from intracellular stores or by influx 
across the plasma membrane from the medium. In order to discriminate between these 
two mechanisms, experiments in the presence of ethyleneglycol-bis(beta-
aminoethylether)-N,N'-tetraacetic
 
acid (EGTA) were performed. Preincubating of  T 
cells with EGTA (4 mM) did not influence the histamine-initiated Ca
2+
 intracellular 
rise, which implicated the mobilization of Ca
2+
 from intracellular stores (data not 
shown). To investigate the involvement of Gi proteins in this response we took 
advantage of pertussis toxin. This toxin uncouples Gi proteins from serpentine receptors 
by ADP-ribosylation. Pretreating  T cells for 1 h with pertussis toxin (100 ng/ml) 
strongly inhibited the histamine-induced Ca
2+
 increase in  T cells, which in turn 
implicated the involvement of Gi proteins in this histamine response (Fig. 3B). To check 
the responsiveness of pertussis-toxin-treated cells, experiments with ionomycin were 
performed. Ca
2+ 
transients induced by ionomycin were not influenced by pertussis toxin 
(data not shown).  
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A)          
          
B)  
       
 
Fig. 3: Histamine induces calcium transients in isolated human peripheral ???汹??桯捹?敳? (A) 
Cells were loaded with Fura-2/AM and stimulated with 0.01 M, 0.1 M, and 1 M histamine. 
Intracellular Ca
2+
 transients were followed by digital fluorescence microscopy and a ratio between 340 
nm and 380 nm was calculated. Representative data from one experiment are shown. Experiments were 
repeated three times with identical results. (B) Cells were pre-incubated with or without pertussis toxin 
(100 ng/ml) for 90 min at 37°C and stimulated with 1 M histamine. The ratio calculated after stimulation 
with and without histamine is shown. Data are means of three different experiments of three different 
donors  SEM.  
 
Next, actin reorganization was analyzed by flow cytometry. A rapid increase in f-actin 
content (circa 60%) was induced when  T cells were stimulated with histamine (Fig. 
4A). The response was transient and reversible, with maximal values reaching within 30 
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seconds. To test the participation of Gi proteins in this response,  T cells were also 
pre-incubated with pertussis toxin before they were exposed to histamine (Fig. 4B). 
Pretreating  T cells with pertussis toxin almost completely abolished the effect of 
histamine on actin polymerization. In contrast pretreating them with cholera toxin did 
not result in a significant difference compared to control cells (Fig. 4C).  
 
A)        
            
 
B)       C)     
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Fig. 4: Effects of histamine on actin polymerization in isolated human-peripheral-blood ? ?捥汬?? 
(A) Cells were exposed to 0.1 M - 1 M histamine and f-actin content was measured by flow cytometry. 
(B) Cells were pre-incubated with or without pertussis toxin (100 ng/ml) for 90 min at 37°C and 
stimulated with 1 M histamine for 30 seconds, and the increase in f-actin content was analyzed. (C) 
Cells were pre-incubated with or without cholera toxin (0.5 μg/ml) for 90 min at 37°C and stimulated 
with 1 M histamine for 30 seconds and the f-actin content was analyzed. All data are means of three 
different experiments using three different donors  SEM, (***: p<0.0001; **: p>0.005; *: p>0.05; ns: 
non-significant).  
 
Intracellular Ca
2+
 transients and actin reorganization are prerequisites for cell migration. 
Therefore, human peripheral blood-isolated  T cells were exposed to different 
concentrations of histamine (0.01 M - 1 M), and migration across the porous-
membrane was evaluated. Histamine induced a typical bell-shaped concentration 
dependent chemotactic response in  T lymphocytes (Fig. 5A). Maximal chemotactic 
responses were observed when cells were stimulated with 0.01 M histamine. 
Moreover, histamine-stimulated migration was abolished by pretreating  T cells with 
pertussis toxin (100 ng/ml) (Fig. 5B). 
 
A)        
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B) 
            
 
Fig. 5: Effects of histamine on chemotaxis in ???捥汬?? Cells were exposed to different histamine 
concentrations (0.001 M - 1 M) in Boyden chambers. Migrated cells in the bottom wells of the Boyden 
chamber were fixed with formalin and counted by flow cytometry. (B)  T cells were pre-treated with 
pertussis toxin for 1h at 37°C, and migration in response to 0.1 M histamine was analyzed. All data are 
means SEM, (***: p<0.0001; **: p>0.005; *: p>0.05). 
 
To specify the subtype of histamine receptor involved in the histamine-induced 
chemotactic response in human peripheral blood  T cells, receptor-selective agonists 
and antagonists were used. The H1R agonist 6-[2-(-imidazolyl)ethylamino]-N-(4-
trifluoromethylphenyl) heptanecarboxamide dimaltate (HTMT), the H2R agonist S-(3-
dimethylaminopropyl) isopthiourea 2HCl (dimaprit-2HCl) and the H3R agonist S-[2-
(imidazol-4-yl)ethyl]isothiourea dihydrobromide (imetit) did not induce any significant 
change in chemotactic activity (Fig. 6A), whereas pretreating  T cells with the H4R 
antagonist N-cyclohexyl-4-(1H-imidazol-4-yl)-1-piperidinecarbothioamide maleate salt 
(thioperamide) prevented histamine-induced migration (Fig. 6B), suggesting that in  T 
cells, migration in response to histamine occurs through H4R. 
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A)        
              
B) 
         
 
Fig. 6: Effects of histamine receptor agonists and antagonists on chemotaxis in ? ?捥汬?? (A) γδ T 
cells isolated from healthy donors were exposed to histamine and isoform-selective agonists HTMT 
(H1R), dimaprit (H2R), and imetit (H3R), and migration was analyzed. (B) γδ T cells were pre-treated with 
the H4R antagonist thioperamide, and the migration assay was performed. All data are means SEM, 
(n=3); (***: p<0.0001; **: p>0.005; *: p>0.05). 
 
3.1.3. Histamine-induced intracellular cAMP levels in  T cells 
 
Histamine is known to affect the intracellular cAMP levels in human dendritic cells via 
H2R and Gs proteins [112]. In order to characterize the functional expression of H2R in 
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isolated human peripheral blood  T cells, intracellular cAMP levels after stimulation 
with histamine were determined by flow cytometry. A significant increase (p<0.0001) 
in cAMP levels, as reflected by increased in mean fluorescence intensity (MFI) was 
observed within 1 minute of histamine treatment (Fig. 7A). Moreover, cAMP levels 
reached a maximum after 4 minutes and remained high 30 minutes after histamine 
stimulation (Fig. 7B).  
 
A)         
                  
B) 
    
Fig. 7: Effect of histamine on intracellular cAMP levels in isolated human-peripheral-blood ?吠
捥汬???(A) Distribution of fluorescence intensity in control cells and  T cells stimulated with 1 µM 
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histamine for 15 min is shown. Aliquots of cells were fixed and stained as described in Materials and 
Methods. Fluorescence intensity was measured by flow cytometry.  Representative data from one 
experiment are shown, performed three times in triplicates. (B) Time course of cAMP levels after 
stimulation with 1 M histamine. Experiments were repeated five times with  T cells isolated from 
different donors. Data are means SEM, (n=5); (***: p<0.0001). 
 
3.1.4. Histamine affects the cytotoxic activity of  T cells in response to tumor cells  
 
We have shown that the activation of Gs-protein-coupled receptors and the upregulation 
of cAMP lead to the downregulation of cytotoxic responses in NK cells [151]. In 
addition,  T cells are known to process cytolytic activity towards different human 
tumor cell lines such as the myeloid leukaemia cell line (K562), cutaneous malignant 
melanoma cells and the non-Hodgkins T cell line Jurkat [99, 155, 156]. To better 
characterize the cytolytic activity of  T cells, in vitro radioactive assays were 
performed using different cell lines. Target cells were labelled for 1 hour with 
chromium (100 Ci/106 cells) and co-cultured for 4 hours at 37C with  T cells t o 
allow spontaneous cytotoxicity. As shown in (Fig. 8A), although  T cells displayed 
cytolitic activity in response all cell lines tested, their lytic capacity was greatest in 
response to K562 cells. Therefore, this cell line was chosen for further experiments to 
analyze the influence of histamine on on the cytolytic activity of  T cells. Histamine 
significantly reduced the cytolytic capacity of  T cells in response to K562 cells at all 
effector:target (E:T) ratios tested (Fig. 8B). 
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A)      
            
B)  
            
 
Fig. 8: Cytotoxic activity of ??捥汬???牯??桥?汴桹?摯湯牳?楮?牥?灯??攠???????爠捥汬?汩?敳? (A)  T 
cells isolated from healthy donors were co-cultured with different tumor cell lines and their spontaneous 
cytolytic capacity was determined. (B)  T cells were stimulated with the indicated concentrations of 
histamine (0.01 M - 10 M) and cytotoxicity in response to the chronic myeloid tumor cell line K562 
was analyzed. Cells were co-cultured in different effector: target (E:T) ratios as indicated. Data are means 
SEM, (n=3); (***: p<0.0001; **: p>0.005; *: p>0.05). 
 
In order to specify which subtype of histamine receptor modulates cytotoxicity in  T 
cells, experiments with receptor-specific agonists and antagonists were performed. 
Isoform-specific H1R- and H3R-agonists did not affect the spontaneous lysis of K562 
cells by  T cells, whereas the H2R-agonist dimaprit significantly reduced the 
spontaneous lysis capacity of  T cells in response to K562 cells (Fig. 9A). Moreover, 
the H4R antagonist did not prevent the histamine-induced effect on cytotoxicity while 
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the H2R-antagonist prevented the histamine-induced effect (Fig. 9B). These experiments 
suggest that the modulatory effect of histamine on  T-cell-mediated cytotoxicity 
requires the activation of the H2R isoform. 
 
A)          
      
B) 
                       
 
Fig. 9: Dimaprit inhibits the cytotoxic activity of ? ?捥汬?? (A)  T cells were stimulated with 1 M 
histamine, 10 µM H1R-agonist HTMT, 10 µM H2R-agonist dimaprit and 0.01 µM H3R-agonist imetit and 
co-cultures with human myeloid cell line K562 were performed in order to analyze the level of cytolytic 
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activity. (B) T cells were stimulated with 1 M histamine in the presence or absence of 10 µM H4R-
antagonist thioperamide, or the H2R-antagonist, cimetidine and co-cultures with the human myeloid cell 
line K562 were performed in order to analyze cytolytic activity. Data are means  SEM, (n=3); (***: 
p<0.0001; **: p>0.005; ns: non-significant). 
 
We next determined the involvement of different G proteins on histamine-modulated 
cytotoxicity. Thus,  T cells were pretreated with Gi protein inhibitor pertussis toxin 
and the Gs activator cholera toxin, and their cytotoxic activity in response to K562 cells 
was examined (Fig. 10). Pertussis toxin did not significantly alter the effect of histamine 
on cytotoxicity. On the contrary, pretreating  T cells with cholera toxin alone 
inhibited cytotoxicity by more than 50% with respect to control cells untreated with 
histamine. This inhibitory effect of the cholera toxin was further enhanced by histamine.  
 
        
 
Fig. 10: Cytotoxic activity of ???捥汬??楮?牥??????? ??????捥汬?汩湥??????楳?摥灥湤敮??????s 
proteins  T cells were pre-incubated with or without cholera toxin (0.5 μg/ml) or pertussis toxin (100 
ng/ml) for 1h at 37°C. Thereafter,  T cells were stimulated or not with histamine and co-cultured with 
K562 cells. Data are means  SEM, (n=3); (***: p<0.0001; ns: non-significant). 
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3.2. fMLP and ?????汬猺?楮癯汶敭??琠??? ??瑵獳??瑯硩 獥?獩瑩癥?????瑩潮??潦?
楳潬慴??????慮? ??楰???慬汯潤??⁬祭??潣祴???
 
The expression of the mRNA of the fMLP receptor was analyzed using reverse 
transcriptase and polymerase chain reaction (RT-PCR). The expected products for the 
fMLP receptor were detected in isolated human-peripheral-blood  T cells by gel 
electrophoresis (Fig. 11A). No PCR-product could be obtained by omitting reverse 
transcription (data not shown). In addition, the expression of fMLP proteins on the 
surface was analyzed. The fMLP expressions on  T cells are shown by flow cytometry 
(Fig. 11B+C).  Neutrophils were used as control cells (Fig. 11D+E).           
A)         
 
B)       C) 
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D)        
 
 
E) 
 
 
Fig. 11: Expression of fMLP mRNA by RT-PCR and surface receptors detected by flow cytometry 
staining in isolated human peripheral blood T lymphocytes. (A)  T lymphocytes isolated from 
human peripheral blood express the mRNA for fMLP receptors. (B;C;D;E)  T lymphocytes express the 
cell surface receptors for fMLPR.  T lymphocytes were isolated and cultured as detailed in Materials 
and Methods. Cells were incubated for 30 min at 4°C with PE-conjugated anti-fMLPR mAb (B:  T 
lymphocytes extracellular staining; C:  T lymphocytes intracellular staining D: neutrophils extracellular 
staining; E: neutrophils intracellular staining). Fluorescence intensity of 10 000 cells/sample was analyzed 
by flow cytometry. Abscissa: fluorescence intensity FL-2H, PE; FL-1H, FITC; ordinate: number of cells. 
 
fMLP is able to induce Ca
2+
 transients in neutrophils [157]. Here, the influence of fMLP 
on Ca
2+
 in  T cells was measured by digital fluorescence microscopy after loading the 
cells with Fura-2. fMLP induced a rapid and concentration-dependent intracellular 
response in human  T cells isolated from peripheral blood (Fig. 12A). Ca2+ transients 
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are mainly created by their mobilization from intracellular stores or by their influx 
across the plasma membrane from the medium. In order to distinguish between these 
two mechanisms, experiments in the presence of EGTA in the medium were performed. 
The preincubation of  T cells with EGTA (4 mM) did not influence the fMLP-
initiated intracellular Ca
2+
 rise, implicating  the mobilization of Ca
2+
 from intracellular 
stores (data not shown). To investigate the involvement of Gi proteins in this response, 
we took advantage of pertussis toxin. This toxin uncouples Gi proteins from serpentine 
receptors by ADP-ribosylation. Pretreating  T cells for 1h with pertussis toxin (100 
ng/ml) inhibited the fMLP-induced Ca
2+
 increase in  T cells (Fig. 12B). To check the 
responsiveness of pertussis-toxin-treated cells, experiments with ionomycin were 
performed. Ca
2+
 transients induced by ionomycin were not influenced by pertussis toxin 
(data not shown).  
 
A)       B)    
      
  
 
Fig. 12: fMLP activation induces intracellular Ca
2+
 transients in human peripheral 吠
汹?灨?捹?敳? (A) Cells were loaded with Fura-2/AM and stimulated with different concentrations of 
fMLP (0.01 μM -1 μM). Intracellular Ca2+ transients were followed in fura2-labelled human peripheral 
blood  T lymphocytes. fMLP induces a rapid and concentration-dependent increase of intracellular 
calcium Ca
2+
. Ionomycin and RANTES were used as positive controls. Changes in fluorescence intensity 
were followed spectrofluorometrically after stimulation of the cells with fMLP, and the ratio between 340 
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nm and 380 nm was calculated. (B) Cells were preincubated with pertussis toxin (100 ng/ml) for 90 min 
at 37°C and stimulated with fMLP (1 μM). Representative data from three experiments using cells 
isolated from different donors are shown.  
 
The reorganization of f-actin is a prerequisite for the migration of different types of 
leukocytes [158, 159]. Next, the influence of fMLP on the f-actin content in human 
peripheral blood  T cells was analyzed by flow cytometry. Rapid f-actin formation 
was induced when  T cells were stimulated with fMLP (Fig. 13A). The increase in f-
actin content upon fMLP stimulation was transient, but extended for at least 5 min. 
Pretreating  T cells with pertussis toxin completely abolished the effect of fMLP on f-
actin polymerization (Fig. 13B). 
 
A)        
        
B) 
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Fig. 13: Effects of fMLP on actin polymerization in isolated human-peripheral-blood ??捥汬?? (A) 
fMLP induced f-actin polymerization in T cells. (B) Cells were pre-incubated without or with pertussis 
toxin (100ng/ml) for 90 min at 37°C and stimulated (10s) with a concentration of 0.2 M fMLP. The 
relative f-actin content after 0s, 10s, 30s, and 300s was measured by flow cytometry. A significant 
increase in f-actin polymerization was observed 30s after fMLP stimulation compared to the untreated 
control. Data are means  SEM, (n=3); (**: p<0.0001; ns: non-significant). 
 
CD11b is known to be the key 2-integrin involved in cell adhesion and leukocyte 
chemotaxis [160]. Thus we measured the influence of fMLP on CD11b expression by 
flow cytometry. fMLP induced a concentration-dependent upregulation of CD11b on 
the surface of human  T lymphocytes (Fig. 14A-B).  
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A) 
                   
B) 
              
 
Fig. 14: fMLP-induced CD11b expression in ??捥汬??  T cells were stimulated with the indicated 
concentrations of fMLP and then incubated for 30 minutes at 37°C. The reaction was stopped by diluting 
the sample to 100 times the original concentration with ice-cold buffer. Samples were incubated for 40 
minutes on ice with PE-conjugated anti-CD11b mAbs and then analyzed by flow cytometry. 
Representative histograms of stimulated (0.01 M - 10 M fMLP) (A-B) and unstimulated anti-CD11b-
stained  T cells are shown. Representative data from three experiments using cells isolated from 
different donors are shown. 
 
Intracellular Ca
2+
 transients, actin reorganization and CD11b expression are 
prerequisites for cell migration in various types of leukocytes. Therefore, isolated 
human-peripheral-blood  T cells were exposed to different concentrations of fMLP 
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(0.01 M - 1 M), and migration across a porous membrane was evaluated. Both fMLP 
induced a typical bell-shaped concentration-dependent chemotactic response in  T 
lymphocytes (Fig. 15A). Again, fMLP-stimulated migration was abolished by 
pretreating  T cells with pertussis toxin (Fig. 15B).  
A) 
           
B) 
      
 
Fig. 15: fMLP-induced chemotaxis of circulating ???敬汳? (A) Cells were exposed to different fMLP 
concentrations (0.1 M-10 M) in Boyden chambers. Migrated cells collected from the bottom wells 
were fixed with formalin and counted by flow cytometry. (B)  T cells were pre-treated with the Gi 
protein inhibitor pertussis toxin. fMLP-induced migration of isolated human-peripheral-blood  T 
lymphocytes is significantly inhibited by pertussis toxin. Data are means SEM, (***: p<0.0001; **: 
p>0.005; ns: non-significant). 
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4. Discussion 
 
4.1.  T cells 
 T cells are thought to be major effector cells in a number of infectious diseases, e.g. 
tuberculosis [66, 67], brucellosis [161], listeriosis [162], leishmaniasis [163], malaria 
[164], and toxoplasmosis [165]. The recruitment and activation of  T lymphocytes to 
sites of inflammation are caused by various agents and natural phosphoantigens derived 
from plants [39], bacteria [40, 41, 166], protozoa [43], endogenous ligands [32, 48, 35, 
49, 167] and viruses [167, 168]. Early events in an immune response involving  T 
cells stimulate the production of cytokines that direct innate host defenses and the 
subsequent development of T cell subsets with discrete patterns of cytokine production. 
 T cells are a population of lymphocytes expressing functional  T cell receptor 
genes [30]. This subtype of T cells, presumably an ancient type of lymphocyte, is 
derived from haematopoietic stem cells that share certain characteristics with other 
immune cells, e.g. the capacity for antigen presentation, immune modulatory properties 
and cytolytic activity [34, 80]. Two main subsets of  T cells are distinguished 
according to their location. Resident  T cells are found in skin, uterine and epithelial 
tissues, whereas circulating/systemic  T cells can be isolated from peripheral blood or 
lymphoid tissues [54, 55]. In contrast to  T lymphocytes,  T cells do not need 
antigens presenting on classical MHC molecules for recognition [55]. Instead, they 
recognize antigens bound to CD1 molecules. [45, 169]. Several lines of evidence 
implicate  T cells in primary host defenses as well as in tumor surveillance. They are 
also known to attack bacterial and virus-bearing cells as well as transformed cells [79]. 
This cytotoxic activity is mediated by the production and release of perforin and 
granzymes [79, 34]. The antitumoral activity of  T cells is either mediated via 
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endogenous ligands in  TCR-dependent fashion or depends on the interaction of the 
cells with NK cell receptor NKG2D [75, 79].   
Different subpopulations of immune cells can infiltrate tumor lesions, although there is 
usually a limited number of T lymphocytes detectable even in those neoplasias (such as 
melanoma) in which the lymphocyte infiltrate appears to correlate with disease course 
[169]. The limited number of T lymphocytes in the microenvironment of tumors 
suggests that mechanisms acting in down-modulating antitumor immune responses are 
likely to be at work [170]. Two lymphocyte subsets T cells and NK cells are frequently 
found within malignant tumors and in the surrounding inflammatory tissue. Fractions of 
these intra- or peritumoral lymphocytes are frequently impaired compared to T and NK 
cells in peripheral blood or in adjacent non-malignant tissue, a phenomenon referred to 
as tumor-induced immunosuppression [171, 172]. Tumor and tumor-associated cells 
actively and directly inhibit immune responses by secreting of immunosuppressive 
cytokines such as interleukin (IL)-10 [173] and transforming growth factor (TGF)- 
[173, 174], as well as by skewing CD4
+ 
T cell responses into TH2 rather than TH1-
dominated immunoreactions [175, 176].  
MCP-1/CCL2 [87], RANTES/CCL5, MIP-1/CCL3 and MIP-1/CCL4 were found to 
be chemically attractive for  T lymphocytes and circulating  T cells, whereas 
neither  nor  responded to IL-8/ CXCL8 or IFN-inducible protein 10 (IP-
10/CXCL10) [89]. The corresponding chemokine receptors are seven-transmembrane-
spanning G-protein-coupled receptors. They share structural features and some of them 
are involved in intrathymic [90], and memory T cell development, others in the 
orchestration of T and B cell interactions and the differentiation of effector T cells [87].  
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4.2. G protein-coupled receptor pathways in circulating  T cells: histamine and 
fMLP receptor pathways 
 
Our data suggest that  T cells´ responses to the stimulation of histamine or fMLP are 
dependent on G protein-coupled receptor pathways. The heterotrimeric G proteins are 
composed of three subunits: ,  and γ. About twenty  subunits have been reported, 
belonging to four families. Two distinct G protein subtypes are sensitive to bacterial 
toxins: cholera toxin ADP-ribosylates the arginine residue present in the carboxy 
terminal of the  subunit of Gs, whereas pertussis toxin ADP-ribosylates the cystein 
residue in the carboxy terminal of the  subunit of Gi or Go proteins [177]. Each G 
protein has a unique biological function. The Gs protein activates adenylyl cyclise, 
resulting in the accumulation of cyclic adenosine monophosphat (cAMP) in the cells. Gi 
proteins are highly homologous members of the family of heterotrimeric signal-
transducing guanine nucleotide-binding proteins (G proteins) and by coupling numerous 
receptors for extracellular signalling molecules to inhibit adenylyl cyclase, stimulate 
phospholipase C, or open potassium channels [9,10]. The activation of phospholipase C 
results in the hydrolysis of phosphatidylinositol bisphosphate (PIP2) and the generation 
of diacylglyceride (DAG), an activator of protein kinase C (PKC), and 
inositol(1,4,5)trisphosphate [12]. 
 
4.2.1. Histamine affects  T cell effector functions: the involvement of pertussis-toxin- 
and cholera-toxin-sensitive functions of isolated human peripheral blood  T 
lymphocytes 
 
Since its discovery in 1910, histamine has been regarded as one of the most important 
mediators in allergy and inflammation and is known to be involved in smooth muscle-
stimulating, vasodepressor action and is involved in reactions during anaphylaxis [178]. 
 62 
Although histamine is located in most body tissues, it is highly concentrated in the 
lungs, skin and gastrointestinal tract [179], where it has been shown to regulate both the 
secretion of gastric acid in the stomach and the functions of several neurological 
transmitters [180, 181]. In the central nervous system, histamine is involved in 
regulating drinking, body temperature, and blood pressure and in perceiving pain [182, 
183]. Histamine has also been described as an autocrine/paracrine or exogenous growth 
factor for cancer cells, e.g. malignant melanomas and leukaemia cells. In the case of 
chronic myeloid leukaemia, the secretion of histamine is the consequence of a 
leukaemia-specific oncogene [107].   
Histamine is known to regulate humoral and cellular immunity by controlling the 
production of pro-inflammatory cytokines, the expression of adhesion molecules and 
the migration of inflammatory cells such as eosinophils, dendritic cells, NK cells and 
 T cells [184, 185]. Histamine and histidine decarboxylase (HDC) [105], the only 
enzyme that catalyzes histamine production, has been proven to be present in elevated 
concentrations in proliferating tissues including tumor cells [157]. In the case of the 
myeloproliferative disease chronic myeloid leukaemia (CML), this gene was the first 
known leukaemia-specific oncogene reported to be involved in the regulation of 
histamine production in neoplastic cells [107]. By mediating the immune response 
histamine also interacts directly with H2 receptors (H2R) on T cells to inhibit T cell 
proliferation and cytokine production [109]. H2R antagonists increase the likelihood that 
patients with gastric and colorectal cancer will survive [186, 187]. Histamine mediates 
the dose-dependent inhibition of human IL-12 and stimulates IL-10 via H2R receptors 
[188]; moreover, it inhibits the IFN-  production of TH1 cells but has no effect on IL-4 
production from TH2 clones [189]. Furthermore, histamine directly enhances the 
production of human IgE from B cells [190], while it inhibits T cell cytotoxicity. 
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Available data suggest that histamine induces a TH2 shift at the level of monocytes 
[191]. 
It has been previously shown that  T cells exposed to histamine do not expand [39]; 
however, our data show that  T cells express three distinct histamine receptor 
subtypes and functionally respond to two of them. To better understand the role of 
histamine in the cross-talk between immune cells and tumor cells, we performed cell 
studies and co-culture experiments with  T cells. Here, we demonstrated that 
histamine stimulates actin polymerization and Ca
2+
 transients in a concentration-
dependent manner and migration in a typical bell-shaped concentration curve. 
Moreover, we showed that the increase in intracellular Ca
2+
 is due to mobilization from 
intracellular stores, inasmuch as it is insensitive to the chelation of extracellular Ca
2+
. A 
long-lasting migration response requires continuous interaction between migration-
inducing ligands and the cell surface receptors that can be activated via actin 
polymerization to induce the “cell motor”. Therefore, a gradient of ligands, continuously 
available cell surface receptors and a very sensitive signal transduction mechanism are 
necessary to transmit the external signal to the internal cellular movement machinery. 
Thus, a low concentration of chemotactic ligands can activate and direct the cell over a 
long period of time. At high ligand concentrations, the receptors at the cell surface are very 
quickly occupied and consequently desensitized as well as internalized via endocytosis. In 
this case, the chemotactic index is low because ligands find no form of receptors at the cell 
surface that can be activated and are not able to induce movement until either novel 
transcriptionally regulated receptors are synthesized or the internalized receptors are 
recycled [192].  
Histamine is able to act by binding to different G protein-coupled receptors. In order to 
demonstrate the participation of Gi proteins in these stimulated cell responses, 
experiments with pertussis toxin were performed. This toxin selectively uncouples Gi 
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proteins from the intracellular sites of receptors by ADP-ribosylation. Pretreating  T 
cells with pertussis toxin blocked histamine-induced actin polymerization, Ca
2+
 
transients and migration in  T cells; these consequences implicate the involvement of 
Gi proteins in these cell responses. Principally, histamine is able to act by binding to 
different receptor subtypes, H1R, H2R, H3R, and H4R.  
In the present work, reverse transcription-polymerase chain reactions revealed the 
mRNA expression of H1R, H2R and H4R in  T cells. No mRNA expression for H3R 
was detected. Moreover, H1R, H2R and H4R expression at the protein level has been 
shown by Western blot analysis. The involvement of the different receptors in these cell 
responses was dissected using isoform-specific receptor agonists and antagonists. Our 
experiments revealed that histamine regulates actin polymerization, Ca
2+
 transients and 
chemotaxis via H4R, but provided no evidence for the involvement of H1R, H2R and 
H3R in these cell responses. This receptor-isoform specific cell regulation is consistent 
with reports in eosinophils, mast cells and NK cells [185, 114]. Therefore, one can 
assume that H4R in  T cells activates pertussis-toxin-sensitive heterotrimeric Gi 
proteins, which in turn dissociate into the guanosine triphosphate- subunit and free γ 
dimers. The latter activates phospholipase C2 [193]. This enzyme cleaves 
phosphatidylinositol (4,5)-bisphosphate into diacylglycerol and the inositol 
trisphosphate, which mobilizes Ca
2+
 from intracellular stores [194]. In leukocytes, Gi 
proteins regulate the reorganization of the actin cytoskeleton independently of activated 
phospholipase C [195]. These Gi-protein-coupled signalling pathways are essential 
components of the migration response in different subtypes of leukocytes [196].   
Unlike classical chemotaxin receptors, such as chemokine receptors or the complement 
C5a receptor, the coupling of different types of histamine receptors is pleiotropic, 
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including the interactions of H2R with Gs proteins with the consequent activation of 
adenylyl cyclase. 
Our cell studies combining histamine and isoform-specific receptor agonists or 
antagonists showed enhanced cAMP levels and H2R activation in  T cells. In different 
subtypes of leukocytes, e.g. NK cells and CD8
+
 T cells, the cytotoxicity response by 
cAMP has been reported to be inhibited [197]. Our data show that the spontaneous 
cytolytic activity of isolated human peripheral blood  T cells is prevented by 
histamine. Neither HTMT nor imetit nor thioperamide altered the spontaneous cytolytic 
capacity of  T cells, but it was inhibited by dimaprit, suggesting that H2R may be 
involved in the inhibitory effect of histamine on the cytotoxicity of  T cells in human 
peripheral blood. Moreover, it has been shown that cholera toxin impairs cytotoxicity in 
 T lymphocytes and NK cells [198].   
As the literature suggests [198], we found that the Gs-protein activator cholera toxin 
inhibited the spontaneous cytotoxicity of  T cells, enhancing cAMP levels. Infiltration 
by lymphocytes, macrophages, mast cells, and neutrophils is a hallmark of 
inflammatory, defense and tissue repair reactions, which are often present in tumors. 
Various types of tumor-infiltrating macrophages and lymphocytes are considered to be 
potential effectors of anti-tumor immunity and may interfere with tumor expression 
[199]. In this work, we showed that histamine, which is present in the inflammatory and 
neoplastic microenvironment, induces the migration of isolated human peripheral blood 
 T cells; in contrast, the spontaneous cytolytic effect of  T cells is prevented by 
histamine [108, 200]. Neither HTMT nor imetit nor thioperamide altered the 
spontaneous cytolytic effect of  T cells, but it was inhibited by dimaprit, suggesting 
that H2R may be involved in the inhibitory effect of histamine on human peripheral 
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blood  T cell-mediated cytotoxicity. Our data suggest that histamine contributes to the 
ability of tumor cells to escape the immunological surveillance. 
 
4.2.2. fMLP affects effector functions of  T cells: the involvement of pertussis-toxin-
sensitive functions of isolated human peripheral blood  T lymphocytes 
 
Gram-negative bacteria-derived and synthetic N-formyl peptides play key chemotactic 
roles for phagocytic cells. N-formyl-Met-Leu-Phe (fMLP) is the prototype for N-
formylated peptides. Its receptor in humans has been pharmacologically defined as a 
high affinity binding site on the surface of phagocytes such as neutrophils [121].  
Natural fMLP was subsequently purified and identified in supernatants of gram negative 
bacteria. Nevertheless, over the past five years, data from several groups have indicated 
that fMLP receptors might act in a more complex manner. A large number of non-
formylated peptide ligands for the fMLP receptor, including derivates of mitochondrial 
proteins, have been identified. Moreover, physiological ligands for the fMLP receptor 
also presumably derive also from viral envelope proteins and the fibriolytic cascade 
[133]. However, it is currently thought that the main effector cells activated by fMLP 
represent phagocytes such as neutrophils, dendritic cells and monocytes. Recently, the 
reduced resistance of fMLP receptor knockout mice to infection by Listeria 
monocytogenes has been reported [201]. Since there is good evidence that  T cells are 
major effector cells in listeriosis, the direct effect of fMLP on cell adhesion and 
migration was analyzed in these cells.  
fMLP exerts its biological functions through three different receptor subtypes: fMLP-
receptor (FPR), and fMLP receptor-like 1 and  2 (FPRL1, FPRL2). Human FPR was 
first defined biochemically as a high affinity binding site for the prototype fMLP on the 
surface of neutrophils. Two additional human genes, designated FPRL1 and FPRL2 
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(FPR-like), were subsequently isolated. [202, 203, 204]. It is generally accepted that 
FPRL1 shares signal transduction features with FPR. Both receptors are sensitive to 
pertussis toxin and possess a high degree of amino acid identity in the cytoplasmic 
signalling domains [205].  
Here, we demonstrated the expression of the fMLP receptor (FPR) surface protein on  
T cells. Moreover, we showed that fMLP stimulates Ca
2+
 transients in  T cells. The 
increase in intracellular Ca
2+
 is due to mobilization from intracellular stores, inasmuch 
as it is insensitive to extracellular chelation by EGTA. Pretreating  T cells with 
pertussis toxin inhibited both fMLP-induced Ca
2+
 transients. This toxin selectively 
uncouples Gi proteins from the intracellular sites of receptors by ADP ribosylation. 
These data suggest that fMLP in  T cells induces similar or identical signal pathways 
as in phagocytes. Binding fMLP to their receptors might induce GDP/GTP exchange in 
the Gi subunit of heterotrimeric G proteins. The activated heterotrimeric G protein 
complex (GTPform) is unstable and dissociates into Gi subunits and free γ dimers, 
which activate phospholipase C2 [194]. This enzyme cleaves phosphatidylinositol 
(4,5)-bisphosphate into diacylglycerol and the inositol trisphosphate, which in turn 
mobilizes Ca
2+
 from intracellular stores
 
[195]. 
In leukocytes, Gi proteins regulate the reorganization of the actin cytoskeleton 
independently of activated phospholipase C [196]. These Gi-protein-coupled signalling 
pathways are essential components of the migratory response in different subtypes of 
leukocytes [197]. To determine whether fMLP-treated cells can initiate the signalling 
required for actin reorganization γδ T cells were activated with different concentrations 
of fMLP (0.1 M - 10 M) labelled with NBD and analyzed by flow cytometry. Rolling 
of the cells is mediated by the selectin family of adhesion molecules and their counter-
structural carbonhydrate ligands, such as sialyl Lewis X, on leukocytes and sulphated 
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polysaccharides, such as fucoidan, on endothelial cells. The more stable adhesion, 
sticking, to the vessel wall is mediated by CD11/CD18 leukocyte adhesion molecules 
(2 integrins) on leukocytes and intercellular adhesion molecules (ICAMs) on 
endothelial cells. After attaching firmly, leukocytes start to migrate across the 
endothelium via intercellular junctions into the subendothelial space. Finally, leukocytes 
become attached to the inflammatory sites a process known as chemotaxis through the 
production of exogenous and endogenous chemoattractant mediators. Exogenous 
chemotaxins include bacterial oligopeptides of the fMLP type, lectins, denatured 
proteins, some lipids and lipopolysaccharides. Endogenous chemotaxins are produced 
by the host organism and are humoral (complement fragment C5a and C3a, 
fibrinopeptides, kallikrein and plasminogen activators) or cellular (from different cells: 
leukotrine B4, platelet activated factor, chemotactic cytokines) [206, 207].  
We demonstrated that fMLP induces actin polymerization and CD11b upregulation in a 
concentration dependent manner and migration in a typical bell-shaped concentration 
curve. The requirements of these cell responses were discussed above already in the 
chapter for histamine. 
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4.3. Conlcusion 
 
The data collected in this work represent the first evidence that G-protein-coupled 
signalling exist in  T cells via histamine and fMLP receptors. The bigenic amine 
histamine and the bacterial peptide fMLP have been demonstrated to be novel 
chemoattractant factors for circulating human  T cells, which are critical members of 
the immunological tumor surveillance machinery. Here, we analyzed the influence of 
histamine on the interaction of human  T cells with tumor cells such as the A2058 
human melanoma cell line, the human Burkitt's non-Hodgkins lymphoma cell line Raji, 
the T-lymphoblastic lymphoma cell line Jurkat, and the NK cell-sensitive 
erythroleukaemia line K562. We found that histamine inhibits the spontaneous cytolytic 
activity of  T cells in response to these cell lines. The downregulation of  T cell 
mediated cytotoxicity involves the histamine receptor subtype 2 (H2R), the activation of 
Gs proteins and increased cAMP intracellular levels. On the other hand, histamine 
activates the common signalling pathways of chemotaxins such as Gi-protein-dependent 
actin reorganization, the increase of intracellular Ca
2+
 and the induction of migratory 
response in  T lymphocytes. Our data indicate that histamine contributes to the 
mechanism by which tumor cells escape immunological surveillance.  
The bacterial-cell-wall-derived peptide N-formyl-Met-Leu-Phe (fMLP) is a well 
characterized chemotactic factor for phagocytes such as neutrophils, monocytes and 
dendritic cells. Here, we analyzed the influence of fMLP on isolated human peripheral 
blood γδ T cells. We found that fMLP induces intracellular calcium transients, actin 
reorganization, CD11b upregulation and the migration of γδ T cells. Pretreating γδ T cells 
with pertussis toxin inhibited all fMLP-stimulated cell responses, implicating the 
involvement of Gi proteins in the induced signalling cascade. The present data suggest that, 
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in addition to phagocytes, N-formyl peptides also regulate the trafficking and activation of 
γδ T cells.  
 
4.4. Outlook 
 
Our data suggest that the responses of circulating human  T cells to histamine are 
mediated by two different G-protein-coupled pathways. Data suggest that the 
downstream pathways of cAMP is involved in the responses of  T cells to histamine 
stimulation. Further analysis of the involvement of phospholipase C (PLC), protein 
kinas B (Akt) and protein kinase A is required.   
 
Figure 4.4.1. The possible G-protein-coupled receptor signalling in  T cells via the histamine receptor subtypes H1R, H2R, H4R. 
Histamine may recruit the  T cells to the site of tumors and inhibit their cytolytic functions. Once there,  T cells secrete different 
chemokines, e.g. RANTES, that may provide tumor development. (Abbreviations: PI3K: phosphatidylinositol 3-kinase; PIP2: 
phosphatidylinositol 4,5-bisphosphate; PIP3: phosphatidylinositol (3,4,5)-trisphosphate; PLC: phospholipase C; DAG: 
diacylglycerol ; PKC: protein kinase C ; IP3 : inositol-1,4,5-trisphosphate; Ca
++ : calcium; Akt: proteinkinase B; cAMP: cyclic 
adenosine-3',5'-monophosphate; H1R, H2R and H4R: histamine receptor subtypes 1,2 and 4; Gi: Gi protein; Gs: Gs protein). 
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Furthermore, in the case of the fMLP receptor pathway in circulating human  T cells, 
further studies analyzing the different subtypes of the fMLP receptor family are required 
to describe the exact receptor pathway involved in the responses of  T cells to fMLP. 
 
 
Figure 4.4.2. The possible G-protein-coupled signalling pathway in  T cells via the fMLP receptor. 
(Abbreviations: PI3K: phosphatidylinositol 3-kinase; PIP2: phosphatidylinositol 4,5-bisphosphate; PIP3: 
phosphatidylinositol (3,4,5)-trisphosphate; PLC: phospholipase C; DAG: diacylglycerol ; PKC: protein 
kinase C ; IP3 : inositol-1,4,5-trisphosphate; Ca
++ 
: calcium; Akt: proteinkinase B; fMLP: N-formyl-Met-
Leu-Phe). 
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